Announcements Trials
Browse Landscape

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 71Neoplasms 70Lung Neoplasms 29Prostatic Neoplasms 26Head and Neck Neoplasms 22Colorectal Neoplasms 19Uterine Cervical Neoplasms 17Ovarian Neoplasms 13Neoplasm Metastasis 13Motor Activity 13Fatigue 11Endometrial Neoplasms 11Colonic Neoplasms 11Brain Neoplasms 11Pain 10Carcinoma, Non-Small-Cell Lung 10Multiple Myeloma 9Melanoma 9Rectal Neoplasms 8Leukemia 8Gastrointestinal Neoplasms 8Smoking Cessation 7Pancreatic Neoplasms 7Lymphoma 7Depression 7cyclopia sequence 6Esophageal Neoplasms 6Carcinoma, Renal Cell 6Advanced Cancer 6Uterine Neoplasms 5

Interventions

Surveys and Questionnaires 1Qigong 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Breast Cancer Survivors × Surveys and Questionnaires × Clear all
NCT02753985 2019-07-23

Adherence to Aromatase Inhibitors: The Role of Partners

Abramson Cancer Center at Penn Medicine

Completed
40 enrolled
Breast

Breast Cancer Survivors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡